321 related articles for article (PubMed ID: 23213063)
1. Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
Yoshio S; Kanto T; Kuroda S; Matsubara T; Higashitani K; Kakita N; Ishida H; Hiramatsu N; Nagano H; Sugiyama M; Murata K; Fukuhara T; Matsuura Y; Hayashi N; Mizokami M; Takehara T
Hepatology; 2013 May; 57(5):1705-15. PubMed ID: 23213063
[TBL] [Abstract][Full Text] [Related]
2. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
Zhang S; Kodys K; Li K; Szabo G
Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
[TBL] [Abstract][Full Text] [Related]
3. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
Zhang S; Saha B; Kodys K; Szabo G
J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
[TBL] [Abstract][Full Text] [Related]
5. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function.
Shiina M; Rehermann B
Hepatology; 2008 Feb; 47(2):385-95. PubMed ID: 18064579
[TBL] [Abstract][Full Text] [Related]
6. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.
Dolganiuc A; Kodys K; Marshall C; Saha B; Zhang S; Bala S; Szabo G
PLoS One; 2012; 7(10):e44915. PubMed ID: 23071503
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
8. Interferon-lambda serum levels in hepatitis C.
Langhans B; Kupfer B; Braunschweiger I; Arndt S; Schulte W; Nischalke HD; Nattermann J; Oldenburg J; Sauerbruch T; Spengler U
J Hepatol; 2011 May; 54(5):859-65. PubMed ID: 21145813
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
Murata K; Sugiyama M; Kimura T; Yoshio S; Kanto T; Kirikae I; Saito H; Aoki Y; Hiramine S; Matsui T; Ito K; Korenaga M; Imamura M; Masaki N; Mizokami M
J Gastroenterol; 2014 Jan; 49(1):126-37. PubMed ID: 23591768
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.
Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS
J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435
[TBL] [Abstract][Full Text] [Related]
12. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.
Lauterbach H; Bathke B; Gilles S; Traidl-Hoffmann C; Luber CA; Fejer G; Freudenberg MA; Davey GM; Vremec D; Kallies A; Wu L; Shortman K; Chaplin P; Suter M; O'Keeffe M; Hochrein H
J Exp Med; 2010 Nov; 207(12):2703-17. PubMed ID: 20975040
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.
Zakaria ZA; Knapp S; Hashem M; Zaghla H; Thursz M; Waked I; Abdelwahab S
Immunol Res; 2019 Feb; 67(1):123-133. PubMed ID: 30402710
[TBL] [Abstract][Full Text] [Related]
14. BDCA3 expression is associated with high IFN-λ production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and/or TGF-β.
van der Aa E; van de Laar L; Janssen HL; van Montfoort N; Woltman AM
Eur J Immunol; 2015 May; 45(5):1471-81. PubMed ID: 25616220
[TBL] [Abstract][Full Text] [Related]
15. IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.
Lalle E; Bordi L; Caglioti C; Garbuglia AR; Castilletti C; Taibi C; Cristofari F; Capobianchi MR
PLoS One; 2014; 9(4):e93434. PubMed ID: 24691098
[TBL] [Abstract][Full Text] [Related]
16. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
[TBL] [Abstract][Full Text] [Related]
17. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2019; 10():112. PubMed ID: 30778353
[No Abstract] [Full Text] [Related]
18. The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.
van der Aa E; Buschow SI; Biesta PJ; Janssen HL; Woltman AM
PLoS One; 2016; 11(8):e0161235. PubMed ID: 27529176
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.
Giugliano S; Kriss M; Golden-Mason L; Dobrinskikh E; Stone AE; Soto-Gutierrez A; Mitchell A; Khetani SR; Yamane D; Stoddard M; Li H; Shaw GM; Edwards MG; Lemon SM; Gale M; Shah VH; Rosen HR
Gastroenterology; 2015 Feb; 148(2):392-402.e13. PubMed ID: 25447848
[TBL] [Abstract][Full Text] [Related]
20. Type III Interferons in Hepatitis C Virus Infection.
Boisvert M; Shoukry NH
Front Immunol; 2016; 7():628. PubMed ID: 28066437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
